Cefepime resistance and associated risk factors among Escherichia coli strains isolated from clinical specimens.

Abstract:

:Cefepime is active against bacteria producing chromosomally and plasmid-mediated extended broad-spectrum β-lactamase enzymes. The aim of this study was to evaluate risk factors for acquisition of cefepime resistance in Escherichia coli strains among hospitalized patients in a university hospital in Sanandaj, Iran. The study was a case-control investigation. A case patient was defined as a patient who had one isolate of a cefepime-resistant E. coli strain. A control patient was defined as a patient who had one isolate of a cefepime-sensitive E. coli strain. Cefepime resistance was determined by HiComb MIC tests (HIMEDIA, India). Out of the 255 total isolates, 73 (28.6%) were resistant to cefepime. The previous treatment of cefepime was a risk factor for acquisition of a cefepime-resistant isolate (OR = 6.32, 95% CI: 1.5-25.19, p < 0.007). The use of a ventilator was considered to be a risk for acquisition of a cefepime-resistant isolate (OR = 6.25, 95% CI: 1.86-21.02, p <0.002). The use of a catheter was also found to be a risk factor for acquisition of cefepime resistance (OR = 6.28, 95% CI: 1.86-21.02, p <0.001). There was a significant correlation between days of stay in hospital wards and cefepime resistance (p < 0.003). The main risk factors associated with cefepime resistance were previous treatment with cefepime, use of ventilator, use of catheter and days of stay in ward. More studies are needed to evaluate the role of these factors in order to control the spread of drug resistance.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Mansouri M,Ramazanzadeh R,Norabadi P

doi

10.1159/000323623

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

134-7

issue

2

eissn

0009-3157

issn

1421-9794

pii

000323623

journal_volume

57

pub_type

杂志文章
  • A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents.

    abstract::The in vitro activity of fleroxacin was determined by broth microdilution against 2,079 recent bacterial isolates and compared to the activities of ciprofloxacin, ofloxacin, lomefloxacin, cefaclor, cefuroxime, cefixime, ceftriaxone, amoxicillin/clavulanate, trimethoprim/sulfamethoxazole (TMP-SMX), and, as appropriate,...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000239386

    authors: Markowitz SM,Williams DS,Hanna CB,Parker JL,Pierce MA,Steele JC Jr

    更新日期:1995-11-01 00:00:00

  • Hepatic arterial infusion with irinotecan in patients with liver metastases of colorectal cancer: results of an extended phase I study.

    abstract:BACKGROUND:To define the maximum tolerated dose (MTD) tolerability and efficacy of intra-arterial chemotherapy with irinotecan in patients with liver metastases of colorectal carcinoma (CRC). METHODS:Superselective intra-arterial irinotecan was applied on days 1, 14, 28 and 42. The initial dose was 140 mg/m² with esca...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000348579

    authors: Eichler K,Dufas T,Hammerstingl R,Gruber-Rouh T,Vogl TJ,Zangos S

    更新日期:2013-01-01 00:00:00

  • Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.

    abstract::After intravenous bolus injection of single doses of 25, 50, 75 and 100 mg of ofloxacin (HOE 280) to 34 healthy male volunteers, concentrations of unchanged drug were estimated at various times in serum and urine over 32 and 48 h. Ofloxacin concentrations were determined using high-pressure liquid chromatography (HPLC...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238567

    authors: Verho M,Korn A,Badian M,Malerczyk V,Waldhäusl W

    更新日期:1988-01-01 00:00:00

  • Antiproliferative effect of somatostatin and analogs.

    abstract::Over the past decade, antiproliferative effects of somatostatin and analogs have been reported in many somatostatin receptor-positive normal and tumor cell types. Regarding the molecular mechanisms involved, somatostatin or analogs mediate their action through both indirect and direct effects. Somatostatin acts throug...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000049159

    authors: Bousquet C,Puente E,Buscail L,Vaysse N,Susini C

    更新日期:2001-01-01 00:00:00

  • Lipid peroxides in the polychemotherapy of cancer patients.

    abstract::There is evidence that a variety of anticancer drugs exert their cytotoxic activity by a free-radical-mediated mechanism. These drugs include anthracyclines such as adriamycin, daunorubicin, 4-epi-adriblastin as well as bleomycin, procarbazine, vincristin, cyclophosphamide, etoposide and mitomycin C. The aim of this s...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239163

    authors: Look MP,Musch E

    更新日期:1994-01-01 00:00:00

  • Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20.

    abstract::The treatment of diffuse large B-cell lymphoma in the presence of cardiac comorbidities can be challenging considering that the standard treatment regimen used for this aggressive subtype of non-Hodgkin lymphoma (NHL) consists of a combination of rituximab, cyclophosphamide, doxorubicin hydrochloride, Oncovin (vincris...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000452756

    authors: Alrifai T,Grant Szymanski K,Venugopal P,Mahon B,Okwuosa T,Karmali R

    更新日期:2017-01-01 00:00:00

  • Surgical suppurating infections and surgical abdominal infections treated with fosfomycin.

    abstract::Two groups of patients suffering surgical infections were treated with fosfomycin. The first includes 21 suppurating dermic of soft underlying tissue lesions. The second group includes 29 surgical abdominal infections. The bacteriology of the first group was made up of gram-positive and gram-negative germs predominant...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222080

    authors: Gallardo A,Sáez JM,Enriquez G,Cobacho AR,Torronteras R,Recordan C,Del Moral A,Arroyo A,Curiel AG

    更新日期:1977-01-01 00:00:00

  • Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.

    abstract:BACKGROUND/AIM:A phase 3 trial of S-1, leucovorin (LV), and oxaliplatin for treating gastric cancer is now underway. However, the antitumor efficacy of the combination has not yet been examined in an in vivo preclinical study. This study examined the antitumor efficacy of combination therapy consisting of S-1, LV, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000486029

    authors: Nagase H,Nakagawa F,Uchida J

    更新日期:2018-01-01 00:00:00

  • Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.

    abstract:BACKGROUND:In this study (part of the global TEST program), the in vitro activity of tigecycline, a member of a new class of antimicrobial agents, the glycylcyclines, against clinical isolates collected in Italy was evaluated. METHODS:A total of 200 clinical isolates were collected and identified in our institution du...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000112415

    authors: Roveta S,Marchese A,Debbia EA

    更新日期:2008-01-01 00:00:00

  • Penetration of clarithromycin into human saliva.

    abstract::The concentrations of clarithromycin after a single oral dose of 500 mg were determined in serum and saliva of ten healthy adult volunteers. After 2 h, the levels were 4.04 +/- 1.14 (SD) mg/l in serum and 2.72 +/- 0.87 mg/l in saliva. After 7 h these values were 1.98 +/- 0.65 and 1.21 +/- 0.34 mg/l, respectively, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239139

    authors: Wüst J,Hardegger U

    更新日期:1993-09-01 00:00:00

  • Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.

    abstract::Ciprofloxacin (CIP) and metabolite concentrations in lung tissue, parietal pleura and bronchial tissue were assessed in 43 adult patients who underwent lung surgery. A single oral dose of CIP was given for prophylaxis of bacterial infections. Two to 6 h prior to tissues sampling, 23 patients received 250 mg and 20 sub...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238860

    authors: Rohwedder R,Bergan T,Caruso E,Thorsteinsson SB,Della Torre H,Scholl H

    更新日期:1991-01-01 00:00:00

  • Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.

    abstract:BACKGROUND:Mutant prevention concentration (MPC) is a new parameter that may be of aid in determining the risk of resistant mutants being selected. METHODS:The MPCs of 224 Mycobacterium tuberculosis clinical isolates were estimated by plating more than 10(10) cells on drug-containing agar and determining the concentra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000085613

    authors: Rodríguez JC,Cebrián L,Ruiz M,López M,Royo G

    更新日期:2005-05-01 00:00:00

  • Acute infantile pneumonopathies treated with fosfomycin.

    abstract::Reference is made to the results obtained in 24 children, from 11 months to 12 years, affected with acute pneumopathies and treated with fosfomycin with a dosage of 200 mg/kg/day. In all cases a clinical, radiological, biological and bacteriological study was carried out. At the same time, levels of fosfomycin in plas...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222069

    authors: Llorens J,Ley G,Forés A,Olay T

    更新日期:1977-01-01 00:00:00

  • Biliary excretion of cefaclor. Experimental and clinical study.

    abstract::Biliary excretion of cefaclor, a new orally active cephalosporin, was studied in vitro using an isolated rabbit liver preparation perfused for 3 h (n = 5). Under these conditions, bile recovery amounted to 2.3% of the cefaclor dose added to the circulating blood (10 mg). In humans, after oral administration of a 1-gra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238075

    authors: Brogard JM,Pinget M,Comte F,Adloff M,Lavillaureix J

    更新日期:1982-01-01 00:00:00

  • Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.

    abstract::Neither cefoperazone, cefotaxime, mezlocillin nor piperacillin significantly killed intraphagocytic bacteria of representative assay strains of Serratia marcescens, as determined with 55 vol% of fresh defibrinated human blood treated with 2 mg/ml of phenylbutazone, which permitted phagocytic ingestion of bacteria, but...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238173

    authors: Traub WH

    更新日期:1983-01-01 00:00:00

  • Antiproliferative properties of toremifene on AIDS-related Kaposi's sarcoma cells.

    abstract:BACKGROUND:Kaposi's sarcoma (KS) is the most common neoplastic apoptosis manifestation of acquired immunodeficiency syndrome. Toremifene is known to upregulate transforming growth factor beta-1 (TGF-beta1), which is a growth-inhibitory factor for KS. We investigated the in vitro effect of toremifene on KS cells. METHO...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000066765

    authors: Hong A,Leigh BR

    更新日期:2002-12-01 00:00:00

  • Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.

    abstract::The activity of aztreonam (a beta-lactam antibiotic with specific activity against gram-negative bacteria) was evaluated and compared with that of tobramycin in hospitalized patients with severe intra-abdominal infections due to gram-negative pathogens, either alone or in association with other bacteria. Of a total st...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238721

    authors: Birolini D,Moraes MF,de Souza OS

    更新日期:1989-01-01 00:00:00

  • Efficacy of oral administration of ofloxacin in lower respiratory tract infections in aged patients with chronic lung disease.

    abstract::The efficacy of ofloxacin for the treatment of lower respiratory tract infection was evaluated in aged patients with chronic lung disease. Results are the following: improvement of leukocytosis and arterial oxygen tension was observed; peripheral blood cell analysis showed a decrease in natural killer cell counts and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238901

    authors: Yamaoka M,Fukuchi Y,Yokouchi M,Teramoto N,Nagase T,Ishida K,Ohtomo E,Orimo H

    更新日期:1991-01-01 00:00:00

  • Murine model for therapy of listeriosis in the compromised host. I. Effect of ampicillin.

    abstract::Therapy of listeriosis with ampicillin was examined in two murine models with compromised defense mechanisms. In mice treated with dextran sulfate paralysing the function of the macrophage system, ampicillin was less able to reduce death rates as well as bacterial counts in the spleens than after infection of normal m...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237980

    authors: Hof H,Emmerling P,Seeliger HP

    更新日期:1981-01-01 00:00:00

  • Influence of fosfomycin on intestinal disaccharidases in rats.

    abstract::The influence of orally administered fosfomycin on intestinal disaccharidases in albino rats was studied. The enzymes were evaluated in a homogenate of the intestinal mucosa, using the method of SOLS and DE LA FUENTE which is based on the colored reaction of the glucose that is freed by the disaccharidases from disacc...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222052

    authors: Casanovas X,Torralba A

    更新日期:1977-01-01 00:00:00

  • Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer.

    abstract:BACKGROUND:The brain is a frequent site of metastases in small-cell lung cancer. Symptoms of cerebral involvement are headache, disorientation, nausea/vomiting and seizures. CASE:A man with small-cell lung cancer developed a human herpesvirus 6 (HHV-6) meningoencephalitis with neurological symptoms that simulated brai...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000360616

    authors: Mordenti P,Zaffignani E,Immovilli P,Nobili E,Cavanna L

    更新日期:2013-01-01 00:00:00

  • The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer.

    abstract:OBJECTIVE:The aim of this study was to assess the value of tumor markers in monitoring chemotherapy response and predicting prognosis in patients with advanced non-small cell lung cancer (NSCLC). METHODS:We studied carcinoembryonic antigen (CEA), CYFRA21-1 and neuron-specific enolase (NSE) of 111 untreated patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000317580

    authors: Jin B,Huang AM,Zhong RB,Han BH

    更新日期:2010-01-01 00:00:00

  • Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.

    abstract::The affinity of meropenem for various known types of beta-lactamases and its stability to them were tested in comparison with other beta-lactams, including imipenem. Meropenem exhibited a marked stability to all beta-lactamases tested and was only hydrolyzed by Xanthomonas maltophilia beta-lactamase, as were other bet...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239004

    authors: Nouda H,Harabe ET,Sumita Y,Okuda T,Fukasawa M

    更新日期:1992-01-01 00:00:00

  • Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

    abstract:BACKGROUND:The prognosis of patients with advanced gastric cancer (AGC) remains poor, and no single chemotherapy regimen is recognized as a global standard. A phase II trial was conducted to determine the efficacy and tolerability of capecitabine and oxaliplatin (XELOX) given every 3 weeks in combination in patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000305256

    authors: Luo HY,Xu RH,Wang F,Qiu MZ,Li YH,Li FH,Zhou ZW,Chen XQ

    更新日期:2010-01-01 00:00:00

  • Effect of linezolid on the phagocytic functions of human polymorphonuclear leukocytes.

    abstract::The effect of linezolid on the phagocytic and bactericidal functions of human polymorphonuclear neutrophils (PMN) against gram-positive cocci was evaluated. Preincubation (30 min; 37 degrees C) of PMN with different concentrations of linezolid (2, 10 and 20 mg/l) did not significantly affect the phagocytosis of either...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000071139

    authors: Ballesta S,Pascual A,García I,Perea EJ

    更新日期:2003-07-01 00:00:00

  • Studies on the phagocytic activity of human and rat polymorphonuclear cells exposed to doxycycline in vivo.

    abstract::Studies are presented on the in vitro phagocytic activity of rat and human polymorphonuclear leukocytes exposed in vivo to therapeutic concentrations of doxycycline. A 32P-labelled strain of Escherichia coli served as test microbe. No significant reduction of ingestion was observed although untreated AB leukocytes tes...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238015

    authors: Melby K,Midtvedt T

    更新日期:1981-01-01 00:00:00

  • Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children. A double-blind clinical trial.

    abstract::Fifty-two children (mean age 23 months) with acute otitis media were treated randomly with either a single intramuscular dose of ceftriaxone (Rocephin) 50 mg/kg (27 patients) or 7 days of amoxicillin 12.5 mg/kg t.i.d. (25 patients). The rate of resolution of acute symptoms and incidence of recurrences and relapses dur...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238646

    authors: Varsano I,Frydman M,Amir J,Alpert G

    更新日期:1988-01-01 00:00:00

  • Pharmacokinetics of flomoxef in mucosal tissue of the middle ear and mastoid following intravenous administration in humans.

    abstract::The pharmacokinetics of flomoxef in serum and in the mucosal tissue of the middle ear and mastoid were studied in 9 patients undergoing tympanoplasties. All patients received 1 g of flomoxef intravenously. Flomoxef levels in serum and in mucosal tissue were determined by a bioassay method. The peak value of mean conce...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238766

    authors: Saito H,Kimura T,Takeda T,Kishimoto S,Oguma T,Shimamura K

    更新日期:1990-01-01 00:00:00

  • Selection of Klebsiella pneumoniae mutants with high-level cefotaxime resistance during growth in serum containing therapeutic concentrations of cefotaxime.

    abstract:BACKGROUND:In a previous investigation of the genetic characterization of extended-spectrum beta-lactamases (ESBLs) in Klebsiella pneumoniae from Zagreb, Croatia, 20 strains were found to produce SHV-2 beta-lactamase. Those strains displayed varying degrees of beta-lactam resistance and a wide range of beta-lactamase a...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048581

    authors: Bedenić B

    更新日期:2002-03-01 00:00:00

  • Susceptibility of Campylobacter pylori isolated from pediatric and adult patients to seven new quinolone antibiotics and nalidixic acid.

    abstract::The susceptibility of 26 strains of Campylobacter pylori to 7 new quinolone antibiotics and nalidixic acid was determined. All strains were resistant to nalidixic acid. Difloxacin, A-56620, A-62254, and ciprofloxacin were equally effective against the test strains with MICs ranging from 0.06 to 2.0 micrograms/ml. Fler...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238589

    authors: Hupertz V,Carr H,Czinn SJ

    更新日期:1988-01-01 00:00:00